iBio (IBIO) Invested Capital (2019 - 2026)
iBio (IBIO) recorded Invested Capital of $85.71 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 443.4% from $15.77 million a year earlier and up 10.5% from the prior quarter.
iBio (IBIO) Invested Capital (2019 - 2026) Analysis & Trends
Starting with fiscal Q4 2019, iBio's Invested Capital history includes 27 quarters.
- Annual Invested Capital has a five-year compound annual growth rate of -4.7% (FY2021 to FY2026).
- Across earlier fiscal years, Invested Capital came in at $15.77 million in FY2025 (-29.8%), $22.49 million in FY2024 (-21.7%), $28.72 million in FY2023 (-66.5%) and $85.65 million in FY2022 (-21.5%).
- The fiscal Q4 2026 figure is the highest quarterly Invested Capital since fiscal Q3 2022.
- On a year-over-year basis, Invested Capital has increased for four consecutive quarters, with growth averaging 161.2% over the last eight quarters.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 529.6% in fiscal Q3 2026, against a decline of 69.4% in fiscal Q3 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $77.54 million (Q3 2026), $56.56 million (Q2 2026) and $56.76 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.66 Mn |
| Mar 31, 2026 | 77.48 Mn |
| Dec 31, 2025 | 56.51 Mn |
| Sep 30, 2025 | 56.76 Mn |
| Jun 30, 2025 | 15.77 Mn |
| Mar 31, 2025 | 12.32 Mn |
| Dec 31, 2024 | 15.29 Mn |
| Sep 30, 2024 | 18.89 Mn |
| Jun 30, 2024 | 22.55 Mn |
| Mar 31, 2024 | 38.52 Mn |
| Dec 31, 2023 | 22.18 Mn |
| Sep 30, 2023 | 26.20 Mn |
| Jun 30, 2023 | 28.72 Mn |
| Mar 31, 2023 | 31.53 Mn |
| Dec 31, 2022 | 35.31 Mn |
| Sep 30, 2022 | 48.36 Mn |
| Jun 30, 2022 | 57.66 Mn |
| Mar 31, 2022 | 101.50 Mn |
| Dec 31, 2021 | 112.65 Mn |
| Sep 30, 2021 | 100.44 Mn |
iBio Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=IBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();